Recent advances on modeling retinal disease: Towards efficient gene/drug therapy

Area of Science:

• Biotechnology
• Ophthalmology
• Genetics

Background:

• Retinal diseases necessitate advanced modeling for personalized treatment development.
• Understanding the interplay of genetics, lifestyle, and environment is crucial for effective therapies.

Purpose of the Study:

• To explore recent advances in diverse study models for retinal disease research.
• To scrutinize the comprehension, advantages, and disadvantages of various retinal models.
• To elucidate innovations from these models for gene and pharmacological therapies.

Main Methods:

• Review of in vivo (human, animal) models.
• Analysis of in vitro systems (cell lines, stem cells, organoids, microfluidics).
• Examination of ex vivo (explant, tissue) and in silico (computational) models.

Main Results:

• Comprehensive overview of current retinal disease modeling techniques.
• Detailed comparison of the strengths and weaknesses of each model type.
• Identification of promising therapeutic advancements derived from these models.

Conclusions:

• Advanced modeling biotechnologies are essential for understanding and treating retinal diseases.
• The selection of appropriate models is critical for successful therapeutic development.
• Innovations in modeling offer significant promise for future gene and pharmacological treatments.